Michael Blue, M.D., FACEP

Michael Blue, M.D., FACEP

Chief Medical Officer

Michael Blue, M.D., FACEP, as Chief Medical Officer, guides Navidea’s product strategy, marketing, and financial performance efforts, with responsibility for the delivery of Navidea’s NAV3-32 and NAV3-33 clinical trials, and the development of expert teams responsible for advancing its innovative technology to market. Prior to his current role, Dr. Blue joined Navidea as Senior Medical Director in 2011, continuing a decorated career of over 40 years in medicine which has included roles within emergency room medicine, cardiometabolic care, service within committees and community focused medical advisory positions, leadership roles within hospitals, and educational roles within multiple universities. His experience also includes having led healthcare related research for a regional venture capital firm. Dr. Blue is former Chairman of the Department of Emergency Medicine at St Ann’s Hospital, former member of the Board of Directors for the Central Ohio Trauma System, and is currently Medical Director for Cardinal Health NPHS. Dr. Blue earned a B.S. in Zoology from Miami University, where he was also Miami’s Scholar Athlete of the Year, and a Doctor of Medicine (M.D.) from the Ohio State University School of Medicine. He holds medical licenses in Ohio, California and Florida, along with ACLS Certification. Dr. Blue is a member of the American College of Emergency Physicians and a Fellow of the American Board of Emergency Medicine, where he also holds a Board Certification in Emergency Medicine (FACEP). Dr. Blue has led or contributed to 16 clinical trials related to Lymphoseek® and concepts related to Navidea’s Manocept platform, and has published extensively in peer reviewed journals throughout his career.

Joseph Meyer

Joseph Meyer

Director, Finance and Accounting

Joseph W. Meyer is a seasoned accounting professional with a proven track record and over a decade of experience implementing and maintaining adherence to GAAP, SEC, FINRA, and NIH/HHS rules and regulations in various accounting functions. He currently serves as the Director of Finance and Accounting at Navidea, where he oversees all finance, accounting, reporting, and compliance areas with the Company. Prior to this role, he held the positions of Controller from April 2022 to March 2023, and Accounting Manager from March 2017 to April 2022, where he oversaw accounting functions which included financial reporting, budgeting, analysis, and payroll. Prior to joining Navidea, Mr. Meyer’s experience includes accounting roles of increasing responsibility at Budenheim USA, MXD Group (now Ryder Last Mile), and Worthington Industries.  Mr. Meyer holds a Bachelor of Business Administration degree in Accounting from Ohio University College of Business.